Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Sep-19 4:15 PM View:  | Lannett Co. Inc. (LCI) | 09-Sep-19 | Market Sale | 16,195 | $12.54 | $203,085.00 | (26%) 62.14K to 45.95K | 47% |
| 06-Sep-19 4:16 PM View: | Lannett Co. Inc. (LCI) | 06-Sep-19 | Sale | 11,582 | $10.30 | $119,295.00 | (16%) 73.72K to 62.14K | |
| 22-Jul-19 4:34 PM View: | Lannett Co. Inc. (LCI) | 19-Jul-19 | Grant | 33,445 | -- | -- | 83% 40.28K to 73.72K | |
| 14-Dec-18 11:25 AM View: | Lannett Co. Inc. (LCI) | 13-Dec-18 | Market Purchase | 10,000 | $5.07 | $50,700.00 | 33% 30.28K to 40.28K | 31% |
| 23-Jul-18 6:21 PM View: | Lannett Co. Inc. (LCI) | 20-Jul-18 | Grant | 16,195 | -- | -- | 115% 14.08K to 30.28K | |
| 25-Jul-17 5:51 PM View: | Lannett Co. Inc. (LCI) | 21-Jul-17 | Grant | 6,977 | -- | -- | 98% 7.11K to 14.08K | |
| 25-Jul-16 5:27 PM View: | Lannett Co. Inc. (LCI) | 22-Jul-16 | Grant | 4,075 | -- | -- | 134% 3.03K to 7.11K | |
| 08-Feb-16 4:14 PM View: | Lannett Co. Inc. (LCI) | 05-Feb-16 | Market Purchase | 2,500 | $24.57 | $61,425.00 | 472% 0.53K to 3.03K | (73%) |
| 10-Sep-14 5:13 PM View: | Allergan Plc (AGN) | 08-Sep-14 | Market Sale | 6,642 | $230.49 | $1,530,910.00 | (23%) 28.5K to 21.86K | 37% |
| 13-May-14 5:23 PM View: | Allergan Plc (AGN) | 09-May-14 | Grant | 1,269 | $197.05 | $250,056.00 | 5% 27.23K to 28.5K | (26%) |
| 13-Nov-13 6:35 PM View: | Allergan Plc (AGN) | 11-Nov-13 | Market Sale | 6,500 | $158.75 | $1,031,880.00 | (19%) 33.73K to 27.23K | 8% |
| 02-Oct-13 9:14 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Oct-13 | Disposition | 33,729 | -- | -- | (100%) 33.73K to 0 | |
| 03-Oct-13 4:31 PM View: | Allergan Plc (AGN) | 01-Oct-13 | Grant | 33,729 | -- | -- | 100% 0 to 33.73K | |
| 02-Oct-13 9:14 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Grant | 16,760 | -- | -- | 50% 33.81K to 50.57K | |
| 02-Oct-13 9:14 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Payment of Exercise | 16,843 | $144.00 | $2,425,390.00 | (33%) 50.57K to 33.73K | 83% |
| 19-Aug-13 4:10 PM View: | Watson Pharmaceuticals Inc. (ACT) | 15-Aug-13 | Market Sale | 5,476 | $135.89 | $744,113.00 | (14%) 39.29K to 33.81K | 82% |
| 08-Mar-13 6:00 PM View: | Watson Pharmaceuticals Inc. (ACT) | 06-Mar-13 | Grant | 6,031 | -- | -- | 18% 33.26K to 39.29K | |
| 07-Mar-13 2:57 PM View: | Watson Pharmaceuticals Inc. (ACT) | 05-Mar-13 | Payment of Exercise | 1,825 | $86.46 | $157,790.00 | (5%) 35.08K to 33.26K | 72% |
| 05-Mar-13 7:24 PM View: | Watson Pharmaceuticals Inc. (ACT) | 05-Mar-13 | Market Sale | 4,413 | $86.05 | $379,739.00 | (11%) 39.49K to 35.08K | 72% |
| 05-Mar-13 7:24 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Mar-13 | Payment of Exercise | 2,028 | $85.54 | $173,475.00 | (5%) 41.52K to 39.49K | 72% |
| 08-May-12 6:17 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-May-12 | Market Sale | 4,000 | $72.77 | $291,084.00 | (9%) 45.52K to 41.52K | 69% |
| 16-Mar-12 2:19 PM View: | Watson Pharmaceuticals Inc. (ACT) | 14-Mar-12 | Payment of Exercise | 1,587 | $59.21 | $93,966.30 | (3%) 47.11K to 45.52K | 62% |
| 12-Mar-12 2:31 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-Mar-12 | Grant | 7,878 | -- | -- | 20% 39.23K to 47.11K | |
| 28-Feb-12 12:23 PM View: | Watson Pharmaceuticals Inc. (ACT) | 24-Feb-12 | Payment of Exercise | 1,782 | $58.17 | $103,659.00 | (4%) 41.01K to 39.23K | 61% |
| 30-Aug-11 4:05 PM View: | Watson Pharmaceuticals Inc. (ACT) | 29-Aug-11 | Market Sale | 1,517 | $66.19 | $100,417.00 | (4%) 42.53K to 41.01K | 66% |
| 18-Mar-11 4:20 PM View: | Watson Pharmaceuticals Inc. (ACT) | 17-Mar-11 | Market Sale | 2,000 | $54.59 | $109,180.00 | (4%) 44.53K to 42.53K | 58% |
| 15-Mar-11 4:14 PM View: | Watson Pharmaceuticals Inc. (ACT) | 11-Mar-11 | Payment of Exercise | 899 | $56.89 | $51,144.10 | (2%) 45.43K to 44.53K | 60% |
| 08-Mar-11 4:32 PM View: | Watson Pharmaceuticals Inc. (ACT) | 05-Mar-11 | Payment of Exercise | 1,511 | $56.79 | $85,809.70 | (3%) 46.94K to 45.43K | 60% |
| 04-Mar-11 4:48 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Mar-11 | Grant | 10,230 | -- | -- | 28% 36.71K to 46.94K | |
| 29-Nov-10 4:45 PM View: | Watson Pharmaceuticals Inc. (ACT) | 29-Nov-10 | Market Sale | 4,000 | $48.44 | $193,760.00 | (10%) 40.71K to 36.71K | 53% |
| 16-Mar-10 5:43 PM View: | Watson Pharmaceuticals Inc. (ACT) | 14-Mar-10 | Payment of Exercise | 1,587 | $41.37 | $65,654.20 | (4%) 42.3K to 40.71K | 45% |
| 26-Feb-10 4:26 PM View: | Watson Pharmaceuticals Inc. (ACT) | 24-Feb-10 | Grant | 13,218 | -- | -- | 45% 29.08K to 42.3K | |
| 13-Mar-09 4:40 PM View: | Watson Pharmaceuticals Inc. (ACT) | 11-Mar-09 | Payment of Exercise | 899 | $27.34 | $24,578.70 | (3%) 29.98K to 29.08K | 15% |
| 06-Mar-09 5:49 PM View: | Watson Pharmaceuticals Inc. (ACT) | 05-Mar-09 | Grant | 11,179 | -- | -- | 59% 18.8K to 29.98K | |
| 14-Mar-08 1:11 PM View: | Watson Pharmaceuticals Inc. (ACT) | 12-Mar-08 | Grant | 12,000 | -- | -- | 176% 6.8K to 18.8K | |
| 27-Jun-07 7:50 PM View: | Watson Pharmaceuticals Inc. (ACT) | 26-Jun-07 | Grant | 6,800 | -- | -- | 100% 0 to 6.8K | |
| 06-Nov-06 4:31 PM View: | Andrx Corp /de/ (ADRX) | 03-Nov-06 | Disposition | 34,494 | $25.00 | $862,350.00 | (100%) 34.49K to 0 | |
| 18-Apr-06 6:13 PM View: | Andrx Corp /de/ (ADRX) | 14-Apr-06 | Payment of Exercise | 679 | $23.69 | $16,085.50 | (2%) 32.5K to 31.82K | |
| 02-Mar-06 7:02 PM View: | Andrx Corp /de/ (ADRX) | 28-Feb-06 | Grant | 10,000 | -- | -- | 374% 2.67K to 12.67K | |
| 03-Jan-06 6:42 PM View: | Andrx Corp /de/ (ADRX) | 01-Jan-06 | Payment of Exercise | 327 | $16.48 | $5,388.96 | (1%) 25.5K to 25.17K | |
| 21-Sep-05 7:26 PM View: | Andrx Corp /de/ (ADRX) | 19-Sep-05 | Grant | 3,750 | -- | -- | 17% 21.75K to 25.5K |